In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

BCL2 is an important regulatory protein of apoptosis pathway, and its abnormal expression is related to the development of various hematologic malignancies. ICP-248 is a novel, orally bioavailable ...

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.